Xontogeny

News

Perceptive Advisors Closes Inaugural $210 Million Perceptive Xontogeny Venture Fund to Support Early-Stage Biotech Startups

Quellis Biosciences Inc. Announces $17 Million Series A Financing

Landos Biopharma Completes $60 Million Series B Financing

Landos Biopharma Raises $10 Million in Series A Financing

Xontogeny Appoints Industry Veteran Fred Callori as Senior Vice President of Corporate Development

Xontogeny, a New Accelerator Operating Company, Launches with a $25 Million Series A Financing to Advance Early Stage Life Sciences Technology through Clinical Proof-of-Concept